Therapeutic approaches targeting the serrated pathway of colorectal cancer characterized by mutation in the BRAF gene and overexpression of GTPase RAC1b

Matos, Paulo; Gonçalves, Vânia; Jordan, Peter

http://hdl.handle.net/10400.18/4917

Use this identifier to reference this record.

Name:	Description:	Size:	Format:
BRAF_RAC1b_book chapter 11_Inflammation and cancer.pdf		522.94 KB	Adobe PDF	Download

Send Feedback

Authors

Matos, Paulo

Gonçalves, Vânia

Jordan, Peter

Abstract(s)

Around 30% of all colorectal cancer cases are derived from the serrated polyp pathway and mostly carry a mutation in the BRAF gene. Here, we review the current knowledge about the association of this tumor subtype with the CpG island methylator and microsatellite instability phenotypes, immune cell infiltration, and overexpression of GTPase Rac1b. The corresponding therapeutic approaches for targeting these molecular characteristics are presented and critically discussed.

Keywords

Colorectal Cancer BRAF RAC1b inflammation Vias de Transdução de Sinal e Patologias Associadas Cancro coloretal inflamação

URI

http://hdl.handle.net/10400.18/4917

Citation

Matos P, Goncalves V, Jordan P (2017). Therapeutic approaches targeting the serrated pathway of colorectal cancer characterized by mutation in the BRAF gene and overexpression of GTPase RAC1b, in: Cho CH (ed), Therapeutic targets for Inflammation and Cancer: Novel Therapies for Digestive Diseases, World Scientific, Singapore, pp 233-255 (ISBN: 978-981-3148-56-7 (print), 978-981-3148-58-1 (e-book)